Denali Therapeutics, Inc. (DNLI)
24.20
-0.72
(-2.89%)
USD |
NASDAQ |
Aug 24, 16:00
23.73
-0.47
(-1.94%)
After-Hours: 20:00
Denali Therapeutics Shareholders Equity (Quarterly) : 835.18M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 835.18M |
| March 31, 2026 | 926.10M |
| December 31, 2025 | 1.014B |
| September 30, 2025 | 926.20M |
| June 30, 2025 | 1.027B |
| March 31, 2025 | 1.123B |
| December 31, 2024 | 1.230B |
| September 30, 2024 | 1.318B |
| June 30, 2024 | 1.387B |
| March 31, 2024 | 1.455B |
| December 31, 2023 | 1.031B |
| September 30, 2023 | 1.118B |
| June 30, 2023 | 1.187B |
| March 31, 2023 | 966.71M |
| December 31, 2022 | 1.042B |
| September 30, 2022 | 811.30M |
| June 30, 2022 | 884.45M |
| March 31, 2022 | 917.93M |
| December 31, 2021 | 962.29M |
| September 30, 2021 | 1.012B |
| Date | Value |
|---|---|
| June 30, 2021 | 1.073B |
| March 31, 2021 | 1.105B |
| December 31, 2020 | 1.151B |
| September 30, 2020 | 882.55M |
| June 30, 2020 | 502.17M |
| March 31, 2020 | 545.31M |
| December 31, 2019 | 394.89M |
| September 30, 2019 | 438.20M |
| June 30, 2019 | 475.17M |
| March 31, 2019 | 516.65M |
| December 31, 2018 | 546.84M |
| September 30, 2018 | 461.18M |
| June 30, 2018 | 490.27M |
| March 31, 2018 | 539.03M |
| December 31, 2017 | 465.80M |
| September 30, 2017 | 193.14M |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 254.52M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Biogen, Inc. | 18.85B |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.158B |
| Total Liabilities (Quarterly) | 322.78M |
| Debt to Equity Ratio | 0.0451 |
| Current Ratio | 8.369 |
| Net Debt Paydown Yield | 0.05% |